Nominations to the Network Portfolio Advisory Group
Submitted by Anonymous (not verified) on 5 November 2024 - 16:03
Nominations to the Network Portfolio Advisory Group
Stakeholder participation in information management
Submitted by Anonymous (not verified) on 5 November 2024 - 15:43
Stakeholder participation in information management
Veterinary medicines European public assessment report (EPAR): Nobivac DP Plus, Canine distemper vaccine (live, attenuated) and canine parvovirus vaccine (live, recombinant), Status: Authorised
Submitted by Anonymous (not verified) on 5 November 2024 - 15:02
Veterinary medicines European public assessment report (EPAR): Nobivac DP Plus, Canine distemper vaccine (live, attenuated) and canine parvovirus vaccine (live, recombinant), Status: Authorised
Veterinary medicines European public assessment report (EPAR): Hiprabovis IBR Marker Live, live gene-deleted vaccine for intramuscular use for active immunisation of cattle against infectious bovine rhinotracheitis, Status: Authorised
Submitted by Anonymous (not verified) on 5 November 2024 - 14:36
Veterinary medicines European public assessment report (EPAR): Hiprabovis IBR Marker Live, live gene-deleted vaccine for intramuscular use for active immunisation of cattle against infectious bovine rhinotracheitis, Status: Authorised
PSUSA/00000007/202312
Submitted by Anonymous (not verified) on 5 November 2024 - 13:25
PSUSA/00000007/202312
Draft consolidated 3-year rolling work plan for the Vaccine Working Party (VWP) - 2025-2027
Submitted by Anonymous (not verified) on 5 November 2024 - 13:15
Draft consolidated 3-year rolling work plan for the Vaccine Working Party (VWP) - 2025-2027
Human medicines European public assessment report (EPAR): Vidaza, azacitidine, Date of authorisation: 17/12/2008, Revision: 28, Status: Authorised
Submitted by Anonymous (not verified) on 5 November 2024 - 13:00
Human medicines European public assessment report (EPAR): Vidaza, azacitidine, Date of authorisation: 17/12/2008, Revision: 28, Status: Authorised
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - October 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 16 October 2024, 10:00 (CEST) to 16 October 2024, 12:00 (CEST)
Submitted by Anonymous (not verified) on 5 November 2024 - 10:38
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - October 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 16 October 2024, 10:00 (CEST) to 16 October 2024, 12:00 (CEST)
EVVet3 EVWeb Production - Release notes
Submitted by Anonymous (not verified) on 5 November 2024 - 10:37
EVVet3 EVWeb Production - Release notes
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - September 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 18 September 2024, 10:00 (CEST) to 18 September 2024, 12:00 (CEST)
Submitted by Anonymous (not verified) on 5 November 2024 - 10:25
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - September 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 18 September 2024, 10:00 (CEST) to 18 September 2024, 12:00 (CEST)